Bệnh hồng cầu lưỡi liềm (ở trẻ em)
Ngăn ngừa khủng hoảng
Phòng chống bệnh hồng cầu lưỡi liềm—Kích hoạt huyết cầu tố thai nhi bằng dược lý cho trẻ em và trẻ sơ sinh bị hồng cầu liềm
Pharmacotherapy in sickle cell disease—state of the art and future prospects. (opens new window)
Nguồn: Br J Haematol 2009;145(3):296-308.
Mã bài: PubMed 19222472
DOI: 10.1111/j.1365-2141.2009.07602.x
https://www.ncbi.nlm.nih.gov/pubmed/19222472 (opens new window)
Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. (opens new window)
Nguồn: Blood 2005;106(7):2269-75.
Mã bài: PubMed 16172253
DOI: 10.1182/Blood-2004-12-4973
https://www.ncbi.nlm.nih.gov/pubmed/16172253 (opens new window)
Hydroxyurea dose escalation for sickle cell anemia in sub-Saharan Africa. (opens new window)
Nguồn: N Engl J Med 2020;382(26):2524-33.
Mã bài: PubMed 32579813
DOI: 10.1056/NEJMoa2000146
https://www.ncbi.nlm.nih.gov/pubmed/32579813 (opens new window)
The effect of hydroxcarbamide therapy on survival of children with sickle cell disease. (opens new window)
Nguồn: Br J Haematol 2013;161(6):852-60.
Mã bài: PubMed 23590693
DOI: 10.1111/bjh.12323
https://www.ncbi.nlm.nih.gov/pubmed/23590693 (opens new window)
Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries. (opens new window)
Nguồn: Arch Dis Child 2013;98(11):908-14.
Mã bài: PubMed 23995076
DOI: 10.1136/archdischild-2012-302387
https://www.ncbi.nlm.nih.gov/pubmed/23995076 (opens new window)
Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. (opens new window)
Nguồn: Pediatrics 2008;122(6):1332-42.
Mã bài: PubMed 19047254
DOI: 10.1542/peds.2008-0441
https://www.ncbi.nlm.nih.gov/pubmed/19047254 (opens new window)
Impact of hydroxyurea on clinical events in the BABY HUG trial. (opens new window)
Nguồn: Blood 2012;120(22):4304-10.
Mã bài: PubMed 22915643
DOI: 10.1182/blood-2012-03-419879
https://www.ncbi.nlm.nih.gov/pubmed/22915643 (opens new window)
Hydroxyurea for children with sickle cell anemia in sub-Saharan Africa. (opens new window)
Nguồn: N Engl J Med 2019;380(2):121-31.
Mã bài: PubMed 30501550
DOI: 10.1056/NEJMoa1813598
https://www.ncbi.nlm.nih.gov/pubmed/30501550 (opens new window)
Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study. (opens new window)
Nguồn: J Pediatr 2002;140(2):225-9.
Mã bài: PubMed 11865275
DOI: 10.1067/mpd.2002.121383
https://www.ncbi.nlm.nih.gov/pubmed/11865275 (opens new window)
Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia. (opens new window)
Nguồn: Pediatrics 2013;132(4):677-83.
Mã bài: PubMed 23999955
DOI: 10.1542/peds.2013-0333
https://www.ncbi.nlm.nih.gov/pubmed/23999955 (opens new window)
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). (opens new window)
Nguồn: Lancet 2011;377(9778):1663-72.
Mã bài: PubMed 21571150
DOI: 10.1016/S0140-6736(11)60355-3
https://www.ncbi.nlm.nih.gov/pubmed/21571150 (opens new window)
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. (opens new window)
Nguồn: Lancet 2016;387(10019):661-70.
Mã bài: PubMed 26670617
https://www.ncbi.nlm.nih.gov/pubmed/26670617 (opens new window)
How I use hydroxyurea to treat young patients with sickle cell anemia. (opens new window)
Nguồn: Blood 2010;115(26):5300-11.
Mã bài: PubMed 20223921
DOI: 10.1182/blood-2009-04-146852
https://www.ncbi.nlm.nih.gov/pubmed/20223921 (opens new window)
Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. (opens new window)
Nguồn: Blood 2004;103(6):2039-45.
Mã bài: PubMed 14630791
DOI: 10.1182/blood-2003-07-2475
https://www.ncbi.nlm.nih.gov/pubmed/14630791 (opens new window)
Phòng chống bệnh hồng cầu lưỡi liềm—Phòng chống nhiễm trùng và biến chứng khác
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. (opens new window)
Nguồn: Cochrane Database Syst Rev 2012;(9):CD003427.
Mã bài: PubMed 22972063
DOI: 10.1002/14651858.CD003427.pub2
https://www.ncbi.nlm.nih.gov/pubmed/22972063 (opens new window)
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial. (opens new window)
Nguồn: Lancet Haematol 2021;8(5):e323-33.
Mã bài: PubMed 33838113
DOI: 10.1016/S2352-3026(21)00059-4
https://www.ncbi.nlm.nih.gov/pubmed/33838113 (opens new window)
Sickle cell disease. (opens new window)
Nguồn: BMJ Clin Evid 2011;02:2402.
Mã bài: PubMed 21718552
https://www.ncbi.nlm.nih.gov/pubmed/21718552 (opens new window)
A phase 3 trial of l-glutamine in sickle cell disease. (opens new window)
Nguồn: N Engl J Med 2018;379(3):226-35.
Mã bài: PubMed 30021096
DOI: 10.1056/NEJMoa1715971
https://www.ncbi.nlm.nih.gov/pubmed/30021096 (opens new window)
Malaria chemoprophylaxis in sickle cell disease. (opens new window)
Nguồn: Cochrane Database Syst Rev 2006;(4):CD003489.
Mã bài: PubMed 17054173
DOI: 10.1002/14651858.CD003489.pub2
https://www.ncbi.nlm.nih.gov/pubmed/17054173 (opens new window)